Background: Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disease presenting clinically by abdominal pain with alteration of bowel habits. Although IBS has uncertain etiology, chronic gut inflammation due to persistent exposure to an infectious agent including Blastocystis sp. was proposed. Aim: to determine the prevalence of Blastocystis hominis infestation in Systemic lupus erythematosus (SLE) patients and determining the immunomodulatory effect of Blastocystis hominis on SLE pathogenesis. Subjects and Methods: A total number of 84 patients attending the SCU hospital outpatient clinics (40 IBS patients / 24 SLE patients / 20 healthy controls) were enrolled in the study and a stool and blood samples were collected. Blastocystis was detected by PCR and serum IL-6 assay by ELISA. Results: Among IBS patients, Blastocystis sp. could be detected at a frequency of 2.5% (1/40), 27.5% (11/40) using direct microscopy and PCR assay respectively while among SLE/IBS patients, it could be detected at a frequency of 8.33% (2/24), 41.66% (10/24). IL-6 assay was higher in PCR positive patients in all study groups. Conclusions: The prevalence of Blastocystis hominis infestation is higher in SLE patients who had IBS compared to IBS patients or asymptomatic controls; with evidence of IL-6 increase in their sera suggesting an immunomodulatory interaction between SLE and Blastocystis hominis.
Introduction
Irritable bowel syndrome (IBS) is considered the commonest cause of referral to gastroenterologists worldwide creating an economic burden for healthcare providers. Several studies have examined the prevalence of IBS in different geographic regions, and in general, have found the prevalence of IBS to be higher in industrialized nations (1, 2) . The actual etiology of IBS is still questionable, and many factors interplay such as psychosocial factors, GIT dysmotility and GIT hypersensitivity (3) . Several parasites including E. histolytica, Giardia sp., B. hominis, and Trichinella sp. have been discussed as contributing factors to the development of IBS, though the relationship is less well defined (4) . Blastocystis hominis is a common gut parasite which is transmitted through the fecal-oral route and exists in many morphological forms such as vacuolar, granular, amoeboid, cyst, avacuolar and multi-vacuolar forms (5) . At least 17 subtypes (STs) of Blastocystis have been identified, with 9 of them (subtype 1 [ST-1] to ST-9) detected in humans (6) . In 2012; Chandramathi et al, reported that Blastocystis in immunosuppressed patients due to chemotherapy tend to exacerbate IBS symptoms (7) , and the same was reported in HIV patients. Some in vitro studies showed the cytopathic effects of Blastocystis sp. on mammalian cell cultures like the study of Long et al, in 2001 ,which showed that 24 h incubation with Blastocystis sp. ST1 cells or culture filtrates induced the production of interleukin IL-8 and granulocyte-macrophage colony-stimulating factor, suggesting that the parasite was able to modulate the host immune response (8) then the later study done Puthia et al, in 2008 showed that IL-8 and IL-6 production from human colonic epithelial cells (HT84) was induced by cysteine proteases from Blastocystis spp. ST4 in a nuclear factor κB dependent manner (9) . Blastocystis exhibits a subtype-dependent upregulation of proinflammatory cytokines and mitogen-activated protein kinase (MAPK) activation in macrophages as Blastocystis ST-4 (WR-1) and ST-7 (B) induces the expression of IL-6, IL-1β, and TNF-α, supporting serine proteases as virulence factors of Blastocystis (10) . Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown pathogenesis which can cause GI symptoms due to primary gastrointestinal disorders or complications of therapy or SLE itself (11) . Patients who have active SLE show increased IL-6 levels in their sera which is correlated with disease activity or anti-DNA levels as showed in many other studies (12) . Elevated IL-6 levels are associated with increased B-cell activity and production of autoantibodies while the secretion of anti-DNA antibodies were reduced by neutralizing IL-6 and restored by adding exogenous IL-6 in vitro (13) . In addition to its systemic actions; IL-6 is a key player in the local inflammatory response encountered in renal, cardiac, pulmonary and neuropsychiatric manifestations of SLE with a growing evidence of its involvement in joint damage in such patients (14) . The rationale of the present study relies on the fact that cytokines are responsible of intercellular signaling which orchestrate the interaction of immune cells during immune responses and sharing IL-6 as a key player between immune disorders like IBD , urticaria , Hashimoto`s thyroiditis and the possible relationship demonstrated by many studies to Blastocystis hominis may points to a link which worth a closer look specially in SLE with disease natural history of multiorgan affection ; this serves as an interesting area to investigate this point.
Patients and Methods
The study aims at determining the prevalence of Blastocystis hominis infestation in patients who have IBS and SLE patients who have IBS compared to normal healthy controls and determining the immunemodulatory effect of Blastocystis hominis on SLE pathogenesis. Using a convince sample technique over a one month period; a total number of 84 subjects (40 IBS patients/24 SLE with IBS patients/20 healthy controls) were enrolled in the study who are attending the internal medicine outpatient clinics (gastroenterology and specialized SLE care services) in Suez Canal University hospitals, Ismailia. SLE patients meeting the Systemic Lupus Collaborating Clinics (SLICC) criteria for SLE diagnosis (15) were included in the study as follows: adult patients ≥ 18 years, on long term immunosuppressive therapy >12 month and had a stable course documented by normal C3 and C4 at least twice in their records during the previous 6 months while diabetic patients were excluded from all study groups to avoid confounding with diabetic gastroparesis. Stool and blood samples were collected. Blastocystis was detected by PCR examining 3 stool samples at different times due to the parasite's irregular shedding in stool. The stool samples were collected in labeled plastic vials without preservatives and subjected to macroscopic examination, direct microscopy with saline/iodine and PCR. (16) and Blastocystis sp. subtypes were identified using classification proposed by Stensvold et al, in 2007 , in which Blastocystis sp. subtypes are identified as n, where n is a designation developed through phylogenetic classification by small-subunit ribosomal DNA analysis (Table 1) (17) . Blood samples were collected in EDTA tubes and centrifuged to obtain the serum samples which were kept at -20°C until serum IL-6 was measured using EnzymeLinked Immunosorbent Assay (Bio-Rad ELISA kit). IBS was diagnosed based on ROME IV diagnostic criteria for functional gastrointestinal disorders as follows: IBS with predominant constipation (IBS-C), IBS with predominant diarrhea (IBS-D), IBS with mixed bowel habits (IBS-M) and IBS unclassified (IBS-U) (18) . Statistical analyses was done using IBM SPSS version 24 were Chi-square test was used to examine the differences in prevalence of Blastocystis in the study groups. IL-6 measurement was analyzed using Student T test. Statistical significance was defined as a p value of <0.05. Table 2 . summarizes the sociodemographic data of the participated patients and controls demonstrating clearly the female gender predominance in SLE/IBS were 100 % (n=24) of the studied population were females which is expected by the natural history of SLE while in IBS group the female forms 57.5 % (n=23) and the studied population mean ages were relatively the same and most of them were from urban rather rural areas. The SLE patients enrolled in the study has a mean disease duration of 7.02 years and 5/24 has hypertension as a comorbid condition and they were maintained in various treatment protocols most commonly Steroid / AZA (11/24) and Steroid/ MMF (7/24) as demonstrated in table 3. Blastocystis sp. was detected in IBS group with direct microscopy in 2.5% (1/40) of patients while using PCR assay the detection improved to 27.5% (11/40) . The same was in SLE/IBS patients, it was detected with direct microscopy in 8.33% (2/24) and with PCR assay in 41.6% (10/24) of the studied patients. Direct wet mount examination of control group failed to detect Blastocystis sp. while PCR assay was able to detect 4 carriers (20%) ( Table 6 provides a detailed information on the symptomatic status of the patients from whom Blastocystis was isolated using PCR based on ROME-IV classification for IBS were the total symptomatic patients were only 32.8% (21/64) while the major set were asymptomatic and the most common presentation was constipation in 17.18 % (11/64) of total symptomatic patients. Moreover; IL-6 was higher in PCR positive patients in all study groups being the highest in SLE patients and the least in control group (29.2±2.9 vs. 13.8±1.8pg/dl) and was statistically significant compared to PCR negative samples (table 7) .
Results

Discussion
Blastocystis sp. was established as a probable causal agent in patients suffering from IBS (19) , however, the exact pathogenic mechanisms is not clearly delineated, except some protease enzymes of Blastocystis sp. that cause mucosal disruption and dysbiosis (20) . Most of the studies related to association of Blastocystis sp. in IBS cohorts were conducted in MiddleEast, Southeast Asia and South-America. In the present study, among IBS patients, Blastocystis sp. was detected at a frequency of 2.5% (1/40), 27.5% (11/40) using direct microscopy and PCR assay respectively, while among SLE/IBS patients, it could be detected at a frequency of 8.33% (2/24), 41.66% (10/24). Direct wet mount examination of control group reveals no detectable samples while by using PCR, only 4 subjects were positive (20%). Concerning the importance of detection of the Blastocystis sp. and PCR being an objective method has been advocated as the method of choice for the detection (21) . Studies from Turkey (22) Pakistan (23) and Italy (24) have also reported significant association of Blastocystis sp. in IBS patients compared to healthy controls. Nevertheless, contrasting results from Mexican studies (25) have shown no difference in the frequency of Blastocystis sp isolation between IBS patients and the controls. (26) , had reported a higher prevalence of Blastocystis sp. in an IBS-D clinical subtypes in Pakistan (44% vs. 21% in controls, p<0.001). On the contrary, study by
Nourrisson et al, (27) from France, did not show any prevalence. The disparity in prevalence of Blastocystis sp.in each clinical subtype of IBS may possibly be explained by the number of IBS patients enrolled in the respective studies. Blastocystis sp. subtype ST 3 was the most common subtype in the present study. In IBS group, it represented 17.5% (7/40), in SLE/IBS group, it represented 25% (6/24) and finally in control group, it represented half of positive samples (2/4). According to the recent study from India (28) In one of the comprehensive study by Yoshikawa et al, (29) , ST3 was the dominant subtype in the four different populations from different countries that included Japan, Bangladesh, Pakistan, and Germany, with a frequency ranging from 41.7% to 92.3%.Study from Columbia has also shown marked association of ST1 being commonly isolated from asymptomatic individuals, ST2 from patients presenting with diarrhea and ST3 exclusively in patients with IBS (30) . The difference in the relative diversity and prevalence of subtypes of Blastocystis sp. probably reflects epidemiological and demographic differences including climatic conditions, geographical attributes, cultural habits, proximity and exposure to reservoir hosts, and mode of transmission (31) .
A study of colonic biopsies of IBD patients showed that GIT symptoms is related to serine protease production (32) which is produced by protozoa to antagonize host immunological factors, such as IgA (33) ; such anti-Blastocystis IgA was involved in all symptomatic, but not asymptomatic, cases of Blastocystis (34) . From this stand point; the theory of that the host attacks the protozoan not the reverse and a resultant disease manifestation is due to the protozoan's defence may explain why carriers of the parasite do not manifest symptoms (35) . Many Parasites are incriminated in diseases of immune nature like arthritis; either by direct joint invasion or by toxin induced production of immune complexes, which leads to exaggerated immune response giving a reason to consider parasitic infestation in cases of autoimmune arthritis like Toxocara canis (36) , Brachiola algerae (37) , Cryptosporidum spp (38) , Giardia lamblia (39) , Strongyloides stercoralis (40) . Furthermore; in Jamaica, physicians report of a female patients with severe arthritis affecting her knees poorly responded to steroid therapy and examination of synovial fluids revealed Blastocystis hominus indicating that it had migrated from the gut to the knee and arthritic activity relieved after metronidazol use (41) . Many reports exists about the relation between Blastocystis hominis and disease conditions like chronic urticaria and Hashimoto`s thyroiditis which are well known autoimmune process and the suggested mechanisms was thought to be due to immune activation induced by the parasite through upregulation to variety of cytokines like IL-1β, IL-6, and TNF-α (42) . SLE is an autoimmune disease of uncertain pathogenesis, characterized by deposition of autoantibodies and immune complexes in various organs leading to systemic manifestations including anywhere in the gut and may be termed lupus enteritis (43) but most of SLE diagnostic criteria do not include them. However oral ulcers are the most common presentation encountered in up to 50% patients; while small and large intestinal abnormalities in SLE may demonstrate itself as dysmotility, vasculitis and malabsorption (44) . Protein-losing enteropathy may be a rare presentation of SLE, and its pathological background and management are not well understood (45) and the association of SLE with IBD is extremely rare (46) . One of the cytokines that modulates SLE activity and has a key action not just in its autoimmune pathogenesis is IL-6 but also (47) in local inflammation like lupus nephritis (48) , lupus carditis, lupus pneumonitis (49) , and arthritis (50) and even in neuropsychiatric manifestations; high IL-6 levels can be detected in cerebrospinal fluid (51) ; this may justify the rationale of this study to investigate IL-6 in GIT manifestation in SLE. Taking in consideration that Blastocystis hominis can cause a leaky gut, which may be a manifestation in many, if not all autoimmune conditions as stated earlier together with it evident association to many cytokines ; the present study offered an evidence for a possible link of Blastocystis hominus and SLE disease process as 41.66 % of the studied SLE patients has Blastocystis hominis infestation proved by PCR mainly subtypes 2 and 3 which is significantly higher when compared to patients with IBS or healthy controls. Moreover; IL-6 assay was higher in PCR positive patients in all study groups confirming the IL-6 / Blastocystis hominus pathogenic link and it is noted that the highest mean IL-6 level was in SLE patients which confirms the study hypothesis. At present; there is insufficient data about the immunomodulatory effect of Blastocystis infestation and the occurrence of SLE, but this study might show an association between both as shown by the significant rise of IL-6 in SLE patients suffering of IBS hope for more researches in this area.
Conclusion
The prevalence of Blastocystis hominis infestation is higher in SLE patients who had IBS compared to IBS patients or asymptomatic controls; with evidence of IL-6 increase in their sera suggesting an immunomodulatory interaction between SLE and Blastocystis hominis.
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